Commentary
Open Access

Medical AI agents in health care: architecture, clinical translation, and trustworthy implementation

Song Yuanlin
Song Yuanlin
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory Internet of Things Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China
,
Bai Chunxue
Bai Chunxue
cxbai@fudan.edu.cn
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory Internet of Things Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China
Author information
Article notes
Funding

Song Yuanlin, Doctoral Degree, Chief Physician; E-mail: song.yuanlin@zs-hospital.sh.cn

Corresponding Author: Bai Chunxue, Doctoral Degree, Chief Physician, Professor; E-mail: cxbai@fudan.edu.cn

Received August 10, 2026; Accepted September 13, 2026; Published September 25, 2026

 Supported by the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529300), the National Natural Science Foundation of China (82570143 and 82170110), the Science and Technology Commission of Shanghai Municipality (20DZ2254400, 21DZ2200600, and 20DZ2261200), the Shanghai Municipal Science and Technology Major Project (ZD2021CY001), and the Shanghai Municipal Key Clinical Specialty (shslczdzk02201).

Commentary
Open Access
Medical AI agents in health care: architecture, clinical translation, and trustworthy implementation
Song Yuanlin
Song Yuanlin
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory Internet of Things Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China
,
Bai Chunxue
Bai Chunxue
cxbai@fudan.edu.cn
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory Internet of Things Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China
Author information

Song Yuanlin, Doctoral Degree, Chief Physician; E-mail: song.yuanlin@zs-hospital.sh.cn

Corresponding Author: Bai Chunxue, Doctoral Degree, Chief Physician, Professor; E-mail: cxbai@fudan.edu.cn

Article notes
Received August 10, 2026; Accepted September 13, 2026; Published September 25, 2026
Funding

 Supported by the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529300), the National Natural Science Foundation of China (82570143 and 82170110), the Science and Technology Commission of Shanghai Municipality (20DZ2254400, 21DZ2200600, and 20DZ2261200), the Shanghai Municipal Science and Technology Major Project (ZD2021CY001), and the Shanghai Municipal Key Clinical Specialty (shslczdzk02201).

PDF
On This Page
CITE
Accesses: 66

Abstract

Clinical care requires iterative evidence acquisition, revision of working hypotheses, and action under incomplete information, changing patient states, and finite resources. Yet medical artificial intelligence (AI) is still evaluated largely through recognition, prediction, content generation, or static question answering. The central scientific question is whether model capability can be translated into safe, effective, and accountable longitudinal clinical action. A medical agent is not merely a large language model (LLM), but a sociotechnical system integrating models, knowledge, data, memory, tools, workflows, human oversight, and governance. Drawing on representative studies, authoritative reviews, reporting guidance, and regulatory documents available through July 2026, this Review proposes a six-module closed-loop architecture—perception, knowledge, reasoning, planning, action, and feedback—clarifies boundaries with related AI systems, and links clinical use cases to evidence and governance requirements. Retrieval-augmented generation, tool use, reflection, and multi-agent collaboration have improved performance in selected controlled tasks. However, static medical question-answering scores are weak proxies for interactive clinical performance, and recent benchmarks show only modest accuracy gains despite substantial increases in token use and latency. A small number of randomized trials and real-world workflow studies suggest potential benefits for documentation, trial prescreening, and bounded decision processes, but do not support unsupervised autonomous diagnosis or treatment. We therefore propose four risk-calibrated autonomy levels, a six-stage evidence pathway, and lifecycle governance. Clinical value should be judged by the net benefit of the clinician–agent–workflow system. The near-term goal is not clinician-independent autonomy, but clinician-led, patient-engaged, evidence-constrained, and accountable human–agent care.


Key Words: medical AI agent; large language model; multi-agent system; clinical translation; human–AI collaboration; trustworthy artificial intelligence; lifecycle governance

Metaverse in Medicine

ISSN: 3006-4236

Volume 3, Issue 3

September 2026

Pages: 147-242

PDF CITE Accesses: 66
Metaverse in Medicine
ISSN: 3006-4236
ZENTIME PUBLISHING CORPORATION LIMITED
On This Page
CITE
On This Page
Abstract